In a major scientific breakthrough, researchers from the Bose Institute, Kolkata, have developed a novel peptide-based therapy that shows strong potential in treating fungal keratitis — a severe and ...

XV, a 15–amino acid human-derived peptide that safely kills fungi causing keratitis, promotes corneal healing, resists drug ...

Michigan hospitals face a rising drug-resistant fungus, Candida auris, highlighting broader concerns over antimicrobial ...

Doctors are reporting a rise in skin rashes and fungal infections during winter, linked to repeatedly wearing unwashed ...

Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...

The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some ...

The contract, awarded by NIH/NIAID, provides up to US $40 million of non-dilutive funding to Vitalex and its collaborator Appili and for the comprehensive development of VXV-01.

The yeast Candida albicans colonizes mucosal surfaces and is usually harmless. However, under certain conditions it can cause dangerous infections.

The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV--01, which was developed ...

The yeast Candida albicans colonizes mucosal surfaces and is usually harmless. However, under certain conditions it can cause dangerous infections. A research team at the University of Zurich has now ...

The fungal infection has been classified as an "urgent antimicrobial resistance threat" by the CDC as cases in Michigan ...

Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.